Author(s):
Neha P. Patil, Divakar R. Patil, Akash S. Jain, Azam Z. Shaikh, Sameer R. Shaikh, S. P. Pawar
Email(s):
bachhavneha713@gamil.com
DOI:
10.52711/2321-5836.2026.00044 
Address:
Neha P. Patil1, Divakar R. Patil2, Akash S. Jain3, Azam Z. Shaikh2, Sameer R. Shaikh2, S. P. Pawar4
1B. Pharm. Student, Department of Pharmaceutics, P.S.G.V.P. Mandal’s College of Pharmacy, Shahada, Maharashtra, India.
2Assistant Professor, Department of Pharmaceutics, P.S.G.V.P. Mandal’s College of Pharmacy, Shahada, Maharashtra, India.
3Assistant Professor, Department of Quality Assurance, P.S.G.V.P. Mandal’s College of Pharmacy, Shahada, Maharashtra, India.
4Principal, P.S.G.V.P. Mandal’s College of Pharmacy, Shahada, Maharashtra, India.
*Corresponding Author
Published In:
Volume - 18,
Issue - 3,
Year - 2026
ABSTRACT:
0.5–1% of children worldwide suffer from epilepsy, a widespread neurological condition that affects people of all genders and demographics. It is a collection of disorders rather than a single illness that is typified by frequent, erratic seizures brought on by aberrant brain activity. These seizures can take many different forms, such as convulsions, sensory or behavioral abnormalities, or loss of consciousness. Recurrent unprovoked seizures, a high likelihood of recurrence, or an epileptic syndrome are the criteria used by the International League Against epileptic (ILAE) to describe epilepsy. Patients' neurological, emotional, and social well-being are greatly impacted by epilepsy, which is caused by neuronal hyperexcitability. Seizure type, EEG results, and related neurological characteristics determine classification. All things considered, epilepsy is a complicated condition with a wide range of causes and symptoms. In children, epilepsy and Attention Deficincy Hyperactivity Disorder (ADHD) often co-occur; approximately 30–40% of children with epilepsy also have ADHD. There are two types of epileptic seizures: focal and generalized. Automatisms, atonic or tonic episodes, clonic jerks, spasms, hyperkinetic movements, or myoclonus are examples of motor symptoms that can accompany focal seizures. Non-motor symptoms include autonomic changes, behavior arrest, cognitive disturbances, emotional changes, or sensory abnormalities. Absence seizures, myoclonic seizures, atonic seizures, tonic seizures, and tonic-clonic seizures are examples of generalized seizures that affect both hemispheres of the brain. This categorization aids in the diagnosis, management, and comprehension of epileptic seizure patterns. A common neurological condition in children, epilepsy is most common in the first year of life and is more common in low- and middle-income nations, where the majority of cases go untreated. The six main categories of its causes are structural, genetic, infectious, metabolic, immunological, and unknown. An imbalance between neuronal excitation and inhibition causes aberrant electrical activity during seizures, which can extend to different parts of the brain. Ion channel malfunction, neurotransmitter imbalance, and altered neuronal circuitry are some of the factors that lead to epileptogenesis and can have long-term repercussions on cognition, particularly following protracted or frequent seizures. When assessing epilepsy, a physical examination is crucial. This includes measuring blood pressure, looking for signs of neurocutaneous syndromes on the skin, and looking for anomalies in the skull that can point to underlying neurological conditions. Electroencephalography (EEG), neuroimaging, and genetic testing are used to diagnose epilepsy in children. Sleep EEG is crucial for focal epilepsies and epileptic encephalopathies. EEG is an easy-to-use method for identifying aberrant cortical excitability. While genetic testing, including next-generation sequencing, has identified over 265 genes associated with epilepsy, increasing the identification of genetic epilepsies, neuroimaging detects structural abnormalities in the brain. Antiepileptic medications including carbamazepine, ethosuximide, and levetiracetam are used in treatment; each is customized for a particular type of seizure and age group while taking side effects and effectiveness into account. An alternate strategy is offered by dietary therapy, especially the ketogenic diet, which lowers seizure frequency by altering neurotransmitter activity and brain metabolism. Together, these therapeutic and diagnostic approaches allow children with epilepsy to be Effecetiveiy managed.
Cite this article:
Neha P. Patil, Divakar R. Patil, Akash S. Jain, Azam Z. Shaikh, Sameer R. Shaikh, S. P. Pawar. Pediatric Epilepsy: Current Perspectives and Emerging Therapies. Research Journal of Pharmacology and Pharmacodynamics.2026;18(3):325-1. doi: 10.52711/2321-5836.2026.00044
Cite(Electronic):
Neha P. Patil, Divakar R. Patil, Akash S. Jain, Azam Z. Shaikh, Sameer R. Shaikh, S. P. Pawar. Pediatric Epilepsy: Current Perspectives and Emerging Therapies. Research Journal of Pharmacology and Pharmacodynamics.2026;18(3):325-1. doi: 10.52711/2321-5836.2026.00044 Available on: https://www.rjppd.org/AbstractView.aspx?PID=2026-18-3-15
REFERENCE:
1. Urbańska SM, Leśniewski M, Welian-Polus I, Witas A, Szukała K, Chrościńska-Krawczyk M. Epilepsy diagnosis and treatment in children – new hopes and challenges – literature review. Journal of Pre-clinical and Clinical Research. 2024; 18(1): 40–49
2. Yash Srivastav a, Akhandnath Prajapati a, Prachi Agrahari b and Madhaw Kumar Review of the Epilepsy, Including Its Causes, Symptoms, Biomarkers, and Management Asian Journal of Research in Medical and Pharmaceutical Sciences. 12(4): 64-84.
3. KD Tripathi. Antiepileptic Drugs. Essentials of Medical Pharmacology. The Health Sciences Publisher. 8th edition (2019).438-451.
4. Manole, A.M.; Sirbu, C.A.; Mititelu, M.R.; Vasiliu, O.; Lorusso, L.; Sirbu, O.M.; Ionita Radu, F. State of the Art and Challenges in Epilepsy—A Narrative Review. J.Pers. Med. 2023; 13: 623.
5. Anwar, H., Khan, Q. U., Nadeem, N., Pervaiz, I., Ali, M., Cheema, F. F., and CMH Lahore Medical College and Institute of Dentistry. Epileptic seizures. Discoveries. 2020; 8(2): e110.
6. Chang, B. S., and Lowenstein, D. H. Epilepsy [Review article]. The New England Journal of Medicine. 2003; 349(13): 1257–1266.
7. Ahmed, G. K., Darwish, A. M., Khalifa, H., and Haridy, N. A. Relationship between Attention Deficit Hyperactivity Disorder and epilepsy: a literature review. The Egyptian Journal of Neurology Psychiatry and Neurosurgery. 2022; 58(1).
8. He, Z., Yang, X., Li, Y., Zhao, X., Li, J., and Li, B. Attention‐deficit/hyperactivity disorder in children with epilepsy: A systematic review and meta‐analysis of prevalence and risk factors. Epilepsia Open. 2024; 9(4): 1148–1165.
9. Saccaro, L.F.; Schlliger, Z. Perroud, N.; Piguet, C. Inflammation, Anxiety, and Stress in Attention-Deficit/Hyperactivity Disorder. Biomedicines. 2021; 9: 1313.
10. KD Tripathi. Antiepileptic Drugs. Essentials of Medical Pharmacology. The Health Sciences Publisher.8th edition (2019).438-451.
11. Anwar, H., Khan, Q. U., Nadeem, N., Pervaiz, I., Ali, M., Cheema, F. F., and CMH Lahore Medical College and Institute of Dentistry. Epileptic seizures. Discoveries. 2020; 8(2): e110.
12. Robert S. Fisher and Anna M. Bonner. The Revised Definition and Classification of Epilepsy for Neurodiagnostic Technologists, The Neurodiagnostic Journal. 2018; 58(1): 1-10.
13. Sarmast S T, Abdullahi A, Jahan N. Current Classification of Seizures and Epilepsies: Scope, Limitations and Recommendations for Future Action. Cureus. 2020; 12(9).
14. Anwar, H., Khan, Q. U., Nadeem, N., Pervaiz, I., Ali, M., Cheema, F. F., and CMH Lahore Medical College and Institute of Dentistry. Epileptic seizures. Discoveries. 2020; 8(2): e110.
15. Ighodaro ET, Maini K, Arya K, et al. Focal Onset Seizure. [Updated 2023 Sep 24]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan.
16. Bromfield EB, Cavazos JE, Sirven JI, editors. An Introduction to Epilepsy [Internet]. West Hartford (CT): American Epilepsy Society; 2006. Chapter 2, Clinical Epilepsy.
17. Fisher, R. S., Cross, J. H., French, J. A., Higurashi, N., Hirsch, E., Jansen, F. E., Lagae, L., Moshé, S. L., Peltola, J., Perez, E. R., Scheffer, I. E., and Zuberi, S. M. Operational classification of seizure types by the International League Against Epilepsy: Position Paper of the ILAE Commission for Classification and Terminology. Epilepsia. 2017; 58(4): 522–530.
18. World Health Organization, International League Against Epilepsy, P.A. Dekker, Tushita Graphic Vision, and Tushita Bosonet. Epilepsy: A manual for Medical and Clinical Officers in Africa (Manual WHO/MSD/MBD/02.02; Revised edition). World Health Organization. 2002
19. Brodie, M. J., Zuberi, S. M., Scheffer, I. E., and Fisher, R. S. The 2017 ILAE classification of seizure types and the epilepsies: what do people with epilepsy and their caregivers need to know? Epileptic Disorders. 2018; 20(2): 77–87.
20. Liman, M. N. P., and Al Sawaf, A. Epilepsy EEG. In NCBI Bookshelf and National Library of Medicine, National Institutes of Health, StatPearls. 2023
21. Chen Z, Brodie MJ, Ding D and Kwan P. Editorial: Epidemiology of epilepsy and seizures. Front. Epidemiol. 2023; 3:1273163.
22. Eslamian M, Shafiei H, Mojahed F, Bahreini A. Prevalence of Epilepsy in Children and Adolescents Worldwide: An Overview of Reviews and Systematic Reviews. Health Provid. 2024; 4(2): 99-108.
23. Beghi E. The Epidemiology of Epilepsy. Neuroepidemiology. 2020; 54(2): 185-191.
24. Vera-González, A. (2022). Pathophysiological mechanisms underlying the etiologies of seizures and epilepsy. In Exon Publications eBooks.
25. Scheffer, I. E., Berkovic, S., Capovilla, G., Connolly, M. B., French, J., Guilhoto, L., Hirsch, E., Jain, S., Mathern, G. W., Moshé, S. L., Nordli, D. R., Perucca, E., Tomson, T., Wiebe, S., Zhang, Y., and Zuberi, S. M. ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology. Epilepsia. 2017; 58(4): 512–521.
26. Etiology and Diagnosis Challenges of Epilepsy: Review. [Journal-article]. International Journal of Healthcare Sciences. 4(2), 2073–2080.
27. Singhi, P. Infectious causes of seizures and epilepsy in the developing world. Developmental Medicine and Child Neurology. 2011; 53(7): 600–609.
28. Dipiro J T, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM, eds. Pharmacotherapy: a pathophysiologic approach. USA: McGraw-Hill Companies Inc, 7th ed. 2008:927-951.
29. Jan, M. M. Clinical review of pediatric epilepsy. In Neurosciences. 2005; 10(4): 255–264.
30. Kaushik JS, Farmania R. Electroencephalography in Pediatric Epilepsy. Indian Pediatr. 2018 Oct 15; 55(10): 893-901.
31. Roy T, Pandit A. Neuroimaging in epilepsy. Ann Indian Acad Neurol. 2011 Apr; 14(2): 78-80.
32. Chang, Y.T.; Hong, S.Y.; Lin, W.D.; Lin, C.H.; Lin, S.S.; Tsai, F.J.; Chou, I.C. Genetic Testing in Children with Developmental and Epileptic Encephalopathies: A Review of Advances in Epilepsy Genomics. Children. 2023; 10: 556.
33. KD Tripathi. Antiepileptic Drugs. Essentials of Medical Pharmacology. The Health Sciences Publisher.7th edition (2019).411-424.
34. Rosati, A., De Masi, S., Guerrini, R., and The Author(s). Antiepileptic Drug Treatment in Children with Epilepsy. In CNS Drugs. 2015; 29(847): 847–863.
35. Arzimanoglou, A., Lösch, C., Garate, P., and Bentz, J. Safety of levetiracetam among infants younger than 12 months – Results from a European multicenter observational study. European Journal of Paediatric Neurology. 2016; 20(3): 368–375.
36. De Brito Sampaio, L. P. Ketogenic diet for epilepsy treatment. Arquivos De Neuro-Psiquiatria. 2016; 74(10): 842–848.